 | • レポートコード：20QY06-07981 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、二重特異性マイトジェン活性化プロテインキナーゼキナーゼ2のグローバル市場について種類別（CIP-137401、CDD-450、MK-2206、硫酸セルメチニブ、その他）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・二重特異性マイトジェン活性化プロテインキナーゼキナーゼ2市場の概要 ・世界の主要地域別二重特異性マイトジェン活性化プロテインキナーゼキナーゼ2市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の二重特異性マイトジェン活性化プロテインキナーゼキナーゼ2市場規模2015-2026：種類別（CIP-137401、CDD-450、MK-2206、硫酸セルメチニブ、その他） ・世界の二重特異性マイトジェン活性化プロテインキナーゼキナーゼ2市場規模2015-2026：用途別（病院、クリニック、その他） ・二重特異性マイトジェン活性化プロテインキナーゼキナーゼ2の北米市場規模2015-2020 ・二重特異性マイトジェン活性化プロテインキナーゼキナーゼ2のヨーロッパ市場規模2015-2020 ・二重特異性マイトジェン活性化プロテインキナーゼキナーゼ2の中国市場規模2015-2020 ・二重特異性マイトジェン活性化プロテインキナーゼキナーゼ2の日本市場規模2015-2020 ・二重特異性マイトジェン活性化プロテインキナーゼキナーゼ2の東南アジア市場規模2015-2020 ・二重特異性マイトジェン活性化プロテインキナーゼキナーゼ2のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Array BioPharma Inc.、AstraZeneca Plc、Confluence Life Sciences, Inc.、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline Plc、Merck & Co., Inc.、Merck KGaA、Novartis AG） ・二重特異性マイトジェン活性化プロテインキナーゼキナーゼ2の製造コスト分析 ・販売チャネル、流通業者、顧客 ・二重特異性マイトジェン活性化プロテインキナーゼキナーゼ2の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market
The global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Scope and Market Size
The global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Dual Specificity Mitogen Activated Protein Kinase Kinase 2 market is segmented into
CIP-137401
CDD-450
MK-2206
Selumetinib Sulfate
Others
Segment by Application, the Dual Specificity Mitogen Activated Protein Kinase Kinase 2 market is segmented into
Hospital
Clinic
Others
The Dual Specificity Mitogen Activated Protein Kinase Kinase 2 market is analysed and market size information is provided by regions (countries). Segment by Application, the Dual Specificity Mitogen Activated Protein Kinase Kinase 2 market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market Share Analysis
Dual Specificity Mitogen Activated Protein Kinase Kinase 2 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dual Specificity Mitogen Activated Protein Kinase Kinase 2 business, the date to enter into the Dual Specificity Mitogen Activated Protein Kinase Kinase 2 market, Dual Specificity Mitogen Activated Protein Kinase Kinase 2 product introduction, recent developments, etc.
The major vendors covered:
Array BioPharma Inc.
AstraZeneca Plc
Confluence Life Sciences, Inc.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
Merck & Co., Inc.
Merck KGaA
Novartis AG
Table of Contents
1 Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market Overview
1.1 Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Product Scope
1.2 Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Segment by Type
1.2.1 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales by Type (2020-2026)
1.2.2 CIP-137401
1.2.3 CDD-450
1.2.4 MK-2206
1.2.5 Selumetinib Sulfate
1.2.6 Others
1.3 Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Segment by Application
1.3.1 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market Estimates and Forecasts (2015-2026)
1.4.1 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Growth Rate (2015-2026)
1.4.2 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue and Growth Rate (2015-2026)
1.4.3 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Price Trends (2015-2026)
2 Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Estimate and Forecast by Region
2.1 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Region (2015-2020)
2.2.2 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue Market Share by Region (2015-2020)
2.3 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Estimates and Projections (2015-2026)
2.4.2 Europe Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Estimates and Projections (2015-2026)
2.4.3 China Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Estimates and Projections (2015-2026)
2.4.4 Japan Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Estimates and Projections (2015-2026)
2.4.6 India Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Estimates and Projections (2015-2026)
3 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Competition Landscape by Players
3.1 Global Top Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Players by Sales (2015-2020)
3.2 Global Top Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Players by Revenue (2015-2020)
3.3 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dual Specificity Mitogen Activated Protein Kinase Kinase 2 as of 2019)
3.4 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Average Price by Company (2015-2020)
3.5 Manufacturers Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Players (Opinion Leaders)
4 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market Size by Type
4.1 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Historic Market Review by Type (2015-2020)
4.1.1 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type (2015-2020)
4.1.2 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue Market Share by Type (2015-2020)
4.1.3 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Price by Type (2014-2020)
4.2 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Forecast by Type (2021-2026)
4.2.2 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue Forecast by Type (2021-2026)
4.2.3 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Price Forecast by Type (2021-2026)
5 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market Size by Application
5.1 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Historic Market Review by Application (2015-2020)
5.1.1 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Application (2015-2020)
5.1.2 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue Market Share by Application (2015-2020)
5.1.3 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Price by Application (2015-2020)
5.2 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Forecast by Application (2021-2026)
5.2.2 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue Forecast by Application (2021-2026)
5.2.3 Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Price Forecast by Application (2021-2026)
3 North America Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market Facts & Figures
3.2 North America Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Company (2015-2020)
3.3 North America Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type (2015-2020)
3.4 North America Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Application (2015-2020)
4 Europe Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market Facts & Figures
4.2 Europe Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Company (2015-2020)
4.3 Europe Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type (2015-2020)
4.4 Europe Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Application (2015-2020)
5 China Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market Facts & Figures
5.2 China Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Company (2015-2020)
5.3 China Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type (2015-2020)
5.4 China Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Application (2015-2020)
6 Japan Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market Facts & Figures
6.2 Japan Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Company (2015-2020)
6.3 Japan Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type (2015-2020)
6.4 Japan Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Application (2015-2020)
7 Southeast Asia Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market Facts & Figures
7.2 Southeast Asia Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Application (2015-2020)
8 India Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market Facts & Figures
8.2 India Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Company (2015-2020)
8.3 India Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type (2015-2020)
8.4 India Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Business
12.1 Array BioPharma Inc.
12.1.1 Array BioPharma Inc. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Corporation Information
12.1.2 Array BioPharma Inc. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Business Overview and Total Revenue
12.1.3 Array BioPharma Inc. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Array BioPharma Inc. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Products Offered
12.1.5 Array BioPharma Inc. Recent Development
12.2 AstraZeneca Plc
12.2.1 AstraZeneca Plc Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Corporation Information
12.2.2 AstraZeneca Plc Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Business Overview and Total Revenue
12.2.3 AstraZeneca Plc Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales, Revenue and Gross Margin (2015-2020)
12.2.4 AstraZeneca Plc Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Products Offered
12.2.5 AstraZeneca Plc Recent Development
12.3 Confluence Life Sciences, Inc.
12.3.1 Confluence Life Sciences, Inc. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Corporation Information
12.3.2 Confluence Life Sciences, Inc. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Business Overview and Total Revenue
12.3.3 Confluence Life Sciences, Inc. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Confluence Life Sciences, Inc. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Products Offered
12.3.5 Confluence Life Sciences, Inc. Recent Development
12.4 F. Hoffmann-La Roche Ltd.
12.4.1 F. Hoffmann-La Roche Ltd. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Corporation Information
12.4.2 F. Hoffmann-La Roche Ltd. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Business Overview and Total Revenue
12.4.3 F. Hoffmann-La Roche Ltd. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales, Revenue and Gross Margin (2015-2020)
12.4.4 F. Hoffmann-La Roche Ltd. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Products Offered
12.4.5 F. Hoffmann-La Roche Ltd. Recent Development
12.5 GlaxoSmithKline Plc
12.5.1 GlaxoSmithKline Plc Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Corporation Information
12.5.2 GlaxoSmithKline Plc Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Business Overview and Total Revenue
12.5.3 GlaxoSmithKline Plc Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GlaxoSmithKline Plc Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Products Offered
12.5.5 GlaxoSmithKline Plc Recent Development
12.6 Merck & Co., Inc.
12.6.1 Merck & Co., Inc. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Corporation Information
12.6.2 Merck & Co., Inc. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Business Overview and Total Revenue
12.6.3 Merck & Co., Inc. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Merck & Co., Inc. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Products Offered
12.6.5 Merck & Co., Inc. Recent Development
12.7 Merck KGaA
12.7.1 Merck KGaA Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Corporation Information
12.7.2 Merck KGaA Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Business Overview and Total Revenue
12.7.3 Merck KGaA Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Merck KGaA Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Products Offered
12.7.5 Merck KGaA Recent Development
12.8 Novartis AG
12.8.1 Novartis AG Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Corporation Information
12.8.2 Novartis AG Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Business Overview and Total Revenue
12.8.3 Novartis AG Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Novartis AG Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Products Offered
12.8.5 Novartis AG Recent Development
13 Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Manufacturing Cost Analysis
13.1 Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Dual Specificity Mitogen Activated Protein Kinase Kinase 2
13.4 Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Distributors List
14.3 Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) Comparison by Application (2020-2026)
Table 3. Global Market Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Region (2015-2020)
Table 5. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Region (2015-2020)
Table 6. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue Share by Region (2015-2020)
Table 8. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue Share Forecast by Region (2021-2026)
Table 12. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 (K Pcs) of Key Companies (2015-2020)
Table 13. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Share by Company (2015-2020)
Table 14. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue Share by Company (2015-2020)
Table 16. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dual Specificity Mitogen Activated Protein Kinase Kinase 2 as of 2019)
Table 17. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Manufacturing Sites and Area Served
Table 19. Manufacturers Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Players
Table 22. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Type (2015-2020)
Table 23. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Share by Type (2015-2020)
Table 24. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Price (K Pcs) by Type (2015-2020)
Table 26. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Share by Type (2021-2026)
Table 27. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue Share by Type (2021-2026)
Table 29. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Price (K Pcs) by Type (2021-2026)
Table 30. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Application (2015-2020)
Table 31. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Share by Application (2015-2020)
Table 32. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Price (K Pcs) by Application (2015-2020)
Table 34. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Application (2021-2026)
Table 35. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Share by Application (2021-2026)
Table 36. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue Share by Application (2021-2026)
Table 38. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Price (K Pcs) by Application (2021-2026)
Table 39. United States Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Company (2015-2020)
Table 40. United States Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Company (2015-2020)
Table 41. United States Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Type (2015-2020)
Table 42. United States Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type (2015-2020)
Table 43. United States Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Application (2015-2020)
Table 44. United States Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Application (2015-2020)
Table 45. Europe Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Company (2015-2020)
Table 47. Europe Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type (2015-2020)
Table 49. Europe Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type (2015-2020)
Table 51. China Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Company (2015-2020)
Table 52. China Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Company (2015-2020)
Table 53. China Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Type (2015-2020)
Table 54. China Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type (2015-2020)
Table 55. China Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Application (2015-2020)
Table 56. China Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Application (2015-2020)
Table 57. Japan Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Company (2015-2020)
Table 59. Japan Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type (2015-2020)
Table 61. Japan Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Application (2015-2020)
Table 69. India Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Company (2015-2020)
Table 70. India Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Company (2015-2020)
Table 71. India Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Type (2015-2020)
Table 72. India Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type (2015-2020)
Table 73. India Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) by Application (2015-2020)
Table 74. India Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Application (2015-2020)
Table 75. Array BioPharma Inc. Corporation Information
Table 76. Array BioPharma Inc. Description and Business Overview
Table 77. Array BioPharma Inc. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Array BioPharma Inc. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Product
Table 79. Array BioPharma Inc. Recent Development
Table 80. AstraZeneca Plc Corporation Information
Table 81. AstraZeneca Plc Description and Business Overview
Table 82. AstraZeneca Plc Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. AstraZeneca Plc Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Product
Table 84. AstraZeneca Plc Recent Development
Table 85. Confluence Life Sciences, Inc. Corporation Information
Table 86. Confluence Life Sciences, Inc. Description and Business Overview
Table 87. Confluence Life Sciences, Inc. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Confluence Life Sciences, Inc. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Product
Table 89. Confluence Life Sciences, Inc. Recent Development
Table 90. F. Hoffmann-La Roche Ltd. Corporation Information
Table 91. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 92. F. Hoffmann-La Roche Ltd. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. F. Hoffmann-La Roche Ltd. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Product
Table 94. F. Hoffmann-La Roche Ltd. Recent Development
Table 95. GlaxoSmithKline Plc Corporation Information
Table 96. GlaxoSmithKline Plc Description and Business Overview
Table 97. GlaxoSmithKline Plc Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. GlaxoSmithKline Plc Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Product
Table 99. GlaxoSmithKline Plc Recent Development
Table 100. Merck & Co., Inc. Corporation Information
Table 101. Merck & Co., Inc. Description and Business Overview
Table 102. Merck & Co., Inc. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Merck & Co., Inc. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Product
Table 104. Merck & Co., Inc. Recent Development
Table 105. Merck KGaA Corporation Information
Table 106. Merck KGaA Description and Business Overview
Table 107. Merck KGaA Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Merck KGaA Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Product
Table 109. Merck KGaA Recent Development
Table 110. Novartis AG Corporation Information
Table 111. Novartis AG Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Novartis AG Description and Business Overview
Table 113. Novartis AG Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Product
Table 114. Novartis AG Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Distributors List
Table 118. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Product Picture
Figure 2. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Others Examples
Figure 9. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Players Market Share by Revenue in Dual Specificity Mitogen Activated Protein Kinase Kinase 2 2015 & 2019
Figure 27. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue Share by Type (2015-2020)
Figure 29. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue Share by Application (2015-2020)
Figure 31. Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type in 2019
Figure 33. United States Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type in 2019
Figure 34. Europe Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Company in 2019
Figure 35. Europe Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type in 2019
Figure 36. Europe Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Application in 2019
Figure 37. China Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Company in 2019
Figure 38. China Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type in 2019
Figure 39. China Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Application in 2019
Figure 40. Japan Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Company in 2019
Figure 41. Japan Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type in 2019
Figure 42. Japan Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Application in 2019
Figure 43. Southeast Asia Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Company in 2019
Figure 44. Southeast Asia Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type in 2019
Figure 45. Southeast Asia Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Application in 2019
Figure 46. India Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Company in 2019
Figure 47. India Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Type in 2019
Figure 48. India Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Sales Market Share by Application in 2019
Figure 49. Array BioPharma Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. AstraZeneca Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Confluence Life Sciences, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. GlaxoSmithKline Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Key Raw Materials Price Trend
Figure 58. Manufacturing Cost Structure of Dual Specificity Mitogen Activated Protein Kinase Kinase 2
Figure 59. Manufacturing Process Analysis of Dual Specificity Mitogen Activated Protein Kinase Kinase 2
Figure 60. Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Industrial Chain Analysis
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. Porter's Five Forces Analysis
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
マイトジェン活性化プロテインキナーゼ9の世界市場レポート2020 Market Analysis and Insights: Global Mitogen Activated Protein Kinase 9 Market The global Mitogen Activated Protein Kinase 9 market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Mitogen Activated Protein Kinas…- プロテインキナーゼ阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Protein Kinase Inhibitor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Protein Kinase Inhib…
- クレアチンキナーゼの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Creatine Kinase market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Creatine Kinase market report…
- がんヤヌスキナーゼ阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cancer Janus Kinase Inhibitor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cancer Janus Ki…
- 含浸活性炭の世界市場レポート2020 Market Analysis and Insights: Global Impregnated Activated Carbon Market The global Impregnated Activated Carbon market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Impregnated Activated Carbon Scope and Mark…